HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modification of the anxiolytic effects of 5-HT1A agonists by shock intensity.

Abstract
Contradictory evidence exists concerning the anxiolytic effects of 5-HT1A agonists in the conflict test. In the present work, a modification of the Vogel conflict model was used to assess different doses of diazepam (0.1-5.6 mg/kg), ipsapirone (1.0-17.8 mg/kg), buspirone (1.7-17.8 mg/kg), and indorenate (0.56-17.8 mg/kg) in rats receiving two different electric shock intensities (0.16 and 0.32 mA). The results show that the three 5-HT1A agonists had a smaller anticonflict effect than diazepam. The anticonflict effect with each compound was of a greater magnitude at 0.16 mA intensity than at 0.32 mA. This study shows that, using different electric shock intensities, compounds produce a differential effect: the anticonflict effects were more pronounced with the lower electric shock intensity than with the higher intensity. The present results suggest that the use of different shock intensities can play distinct roles over the drug's effect in the conflict test.
AuthorsA Meneses, E Hong
JournalPharmacology, biochemistry, and behavior (Pharmacol Biochem Behav) Vol. 46 Issue 3 Pg. 569-73 (Nov 1993) ISSN: 0091-3057 [Print] United States
PMID7904070 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Anxiety Agents
  • Pyrimidines
  • Receptors, Serotonin
  • Serotonin Receptor Agonists
  • 5-Methoxytryptamine
  • ipsapirone
  • indorenate
  • Diazepam
  • Buspirone
Topics
  • 5-Methoxytryptamine (analogs & derivatives, pharmacology)
  • Animals
  • Anti-Anxiety Agents (pharmacology)
  • Buspirone (pharmacology)
  • Conditioning, Operant (drug effects)
  • Conflict, Psychological
  • Diazepam (pharmacology)
  • Electroshock
  • Male
  • Pyrimidines (pharmacology)
  • Rats
  • Rats, Wistar
  • Receptors, Serotonin (drug effects)
  • Serotonin Receptor Agonists (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: